Karen Zaderej

Track

Insider profile

Currently holds a position at AxoGen Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 18% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
10 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer AxoGen Inc May 21, 2018 -
Independent Director Viveve Medical Inc Sept. 13, 2018 - May 4, 2020
President, Chief Executive Officer, Director AxoGen Inc Sept. 30, 2011 - May 21, 2018
Karen Zaderej's trades of EyePoint Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-19 2025-05-19
US EyePoint Inc (EYPT)
B Purchase
93,394 -36.4%
63.77
US$1,751,587 		93,394 -36.4% 63.77 US$1,751,587
2025-05-19 2025-05-16
US EyePoint Inc (EYPT)
B Purchase
63,270 -18.8%
163.49
US$3,560,782 		63,270 -18.8% 163.49 US$3,560,782
2025-05-15 2025-05-15
US EyePoint Inc (EYPT)
B Purchase
17,170 +43.4%
251.55
US$1,495,756 		17,170 +43.4% 251.55 US$1,495,756
2025-05-15 2025-05-14
US EyePoint Inc (EYPT)
B Purchase
5,000 +30.3%
5.42
US$27,100 		5,000 +30.3% 5.42 US$27,100
2025-01-21 2025-01-21
US AxoGen Inc (AXGN)
PrS Proposed sale
220,000
18.41
US$4,050,000 		220,000 18.41 US$4,050,000
2025-01-14 2025-01-14
US AxoGen Inc (AXGN)
PrS Proposed sale
100,000
18.00
US$1,800,000 		100,000 18.00 US$1,800,000
2024-11-07 2024-11-07
US AxoGen Inc (AXGN)
PrS Proposed sale
70,000
12.71
US$890,000 		70,000 12.71 US$890,000
2024-09-05 2024-09-05
US AxoGen Inc (AXGN)
PrS Proposed sale
150,000
13.00
US$1,950,000 		150,000 13.00 US$1,950,000
2024-08-21 2024-08-19
US EyePoint Inc (EYPT)
B Purchase
12,500 +312.5%
7.98
US$99,750 		12,500 +312.5% 7.98 US$99,750
2024-08-12 2024-08-12
US AxoGen Inc (AXGN)
PrS Proposed sale
200,000
10.00
US$2,000,000 		200,000 10.00 US$2,000,000
2024-03-25 2024-03-21
US AxoGen Inc (AXGN)
S Sale
3,166 -0.3%
7.68
US$24,315 		3,166 -0.3% 7.68 US$24,315
2024-03-25 2024-03-21
US AxoGen Inc (AXGN)
S Sale
3,086 -0.3%
7.68
US$23,700 		3,086 -0.3% 7.68 US$23,700
2024-03-25 2024-03-21
US AxoGen Inc (AXGN)
S Sale
33,028 -2.9%
7.68
US$253,655 		33,028 -2.9% 7.68 US$253,655
2021-01-12 2021-01-08
US AxoGen Inc (AXGN)
PlS Planned sale
65,000 -9.6%
20.00
US$1,300,000 		65,000 -9.6% 20.00 US$1,300,000
2020-12-30 2020-12-29
US AxoGen Inc (AXGN)
S Sale
3,500 -0.5%
17.81
US$62,335 		3,500 -0.5% 17.81 US$62,335
2020-12-22 2020-12-21
US AxoGen Inc (AXGN)
S Sale
1,275 -0.2%
16.42
US$20,936 		1,275 -0.2% 16.42 US$20,936
2020-11-10 2020-11-09
US AxoGen Inc (AXGN)
PlS Planned sale
14,000 -2.1%
14.53
US$203,420 		14,000 -2.1% 14.53 US$203,420